Why the study?
Is adiponectin independently associated with insulin sensitivity in women with polycystic ovary syndrome?
Population
62 women with polycystic ovary syndrome (PCOS) and 35 healthy female controls
Comparison
Metformin treatment for 6 months vs Healthy female controls
Design
Cross-sectional
Follow-up
6 months (for metformin subset)
Authors
Loading...
Adiponectin may mark partial insulin resistance in PCOS but is unaffected by metformin; leaves open any therapeutic targeting.
Is adiponectin independently associated with insulin sensitivity in women with polycystic ovary syndrome?
Adiponectin is independently associated with insulin resistance in PCOS women, independent of adiposity, but is not directly altered by PCOS itself or metformin therapy.
Spranger et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: